Welcome to our dedicated page for Aehr Test Sys SEC filings (Ticker: AEHR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Aehr Test Systems (NASDAQ: AEHR) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a California-based supplier of semiconductor test and burn-in systems, Aehr uses these filings to report on financial performance, corporate governance, equity compensation plans, and other material events.
Investors can review current reports on Form 8-K, where Aehr discloses items such as quarterly and annual financial results, amendments to equity incentive and employee stock purchase plans, and outcomes of shareholder votes at its annual meetings. For example, recent 8-K filings describe the approval of amendments to the 2023 Equity Incentive Plan and the Amended and Restated 2006 Employee Stock Purchase Plan, as well as the ratification of the company’s independent registered public accounting firm.
The company’s proxy statement on Schedule DEF 14A provides detail on director elections, executive compensation proposals, advisory votes on pay and pay frequency, and the matters submitted to shareholders at the annual meeting. These documents help investors understand Aehr’s board structure, compensation programs, and shareholder voting results.
On Stock Titan, Aehr’s filings are updated in near real time from EDGAR. Users can access 8-Ks for earnings announcements and other material events, proxy materials for governance and compensation information, and related exhibits referenced in those filings. AI-powered summaries highlight key points, allowing readers to quickly see how developments in Aehr’s semiconductor test and burn-in business—spanning FOX wafer-level systems and Sonoma, Echo, and Tahoe package-level platforms—are reflected in its official disclosures.
Aehr Test Systems (AEHR) has filed a Form 144, indicating a proposed sale of 18,000 common shares through Fidelity Brokerage Services. The shares have an aggregate market value of $356,972.22 and represent roughly 0.06% of the 29.77 million shares outstanding. The filer plans to execute the sale on or about 07/22/2025. The shares were acquired via an employee stock option granted on 08/17/2018 and are to be paid for in cash upon exercise. No other sales by the filer were reported during the past three months.
The notice contains no earnings data or operational updates; it simply alerts the market to a small potential insider transaction. Given the limited size relative to the company’s float, the filing is unlikely to be material to AEHR’s valuation or liquidity.